Home Insider News Zentalis Pharmaceuticals Inc. Insider Just Sold 26,794 Shares. Should You?

Zentalis Pharmaceuticals Inc. [ZNTL] Insider Just Sold 26,794 Shares. Should You?

On Jan. 04, Sun Anthony Y divested U.S. $1,394,907 in shares of Zentalis Pharmaceuticals Inc.. The Pres, CEO sold 26,794 shares at a price per share of $52.06. The transaction decreased this specific insider’s holdings to 2,965,113 shares worth around $144.43 million at present.

Another 10,000 shares were sold by Gallagher Cam, for more than $519,323 in total proceeds. The Dir dumped the shares at a price of $51.93 and the insider now owns almost 570,192 shares.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


That same day, Bunker Kevin D. sold 34,987 shares. The COO divested U.S. $1,821,116 in shares of Zentalis Pharmaceuticals Inc. at a price per share of $52.05. The transaction decreased this specific insider’s holdings to 1,101,493 shares worth around $53653724.03 at present.

Epperly Melissa B, sold 3,083 shares. The CFO divested U.S. $160,034 in shares of Zentalis Pharmaceuticals Inc. at a price per share of $51.91. The transaction decreased this specific insider’s holdings to 274,596 shares worth around $13375571.16 at present.

Cantor Fitzgerald launched its Zentalis Pharmaceuticals Inc. [ZNTL] rating to the equivalent of an Overweight and assigned the price target of $44, in a research note dated September 29, 2020. That figure represents around a -10.7% premium from where the company’s shares closed on Wednesday. Some new analysts also started their coverage, with Cantor Fitzgerald’s analysts assigning the shares to “an Overweight” rating in a research note to investors issued in late September. Meanwhile, H.C. Wainwright had launched its coverage on ZNTL with “Buy”, in a research note produced for clients August 27, 2020. In addition, there was a new coverage from SVB Leerink on April 28, 2020. The research firm rated ZNTL “an Outperform”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

ZNTL Price Performance

On Wall Street, Zentalis Pharmaceuticals Inc. [NASDAQ:ZNTL] finished Wednesday’s session down -6.54% at $48.71. The stock went up to $52.28 at the same session while its lowest single day price was $46.83. In the last five days, it saw a fall of about -10.69%, Zentalis Pharmaceuticals Inc. shares dropped by almost -6.22% since the beginning of the year. However, the share price has dropped to as low as -20.53% below its one year high.

ZNTL Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 46.27 level, and in case of violation of this particular level, it will cause more drop to 43.82 level. On the upper level, 54.72 is still the key resistance. The stock may increase to the subsequent resistance at 51.72. The Relative Strength Index (RSI) pinned on the 14-day chart is 42.99, implying a neutral technical stance while the MACD stands at -2.04, meaning price will decrease in the next trading period. Percent R indicator moved to 84.11%, implying bearish price movement. Stochastic %K at 26.75% suggest holding the stock.

What is the short interest in Zentalis Pharmaceuticals Inc.?

Short interest in the Zentalis Pharmaceuticals Inc. stock has surged, increasing by 0.24 million shares to total 1.9 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 2.14 million, data from Yahoo Finance shows. The decrease of -12.63% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 11.75% of the overall float for the stock.

Zentalis Pharmaceuticals Inc.’s Biggest Shareholders: Who Owns Zentalis Pharmaceuticals Inc. [ZNTL]?

Filings by Viking Global Investors LP showed that the firm now holds a total of 3,943,284 shares or roughly 9.71% of the outstanding ZNTL shares. This means their shares have reduced by -500,000 from the 3,943,284 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, Matrix Capital Management Co. LP updated stake is worth $194,755,819. Details in the latest 13F filings reveal that Fidelity Management & Research Co acquired their 23.36% stake valued at $145,272,691 while Tybourne Capital Management cut theirs at $135,778,283. During the last quarter, Fidelity Management & Research Co raised 539,774 of its shares in Zentalis Pharmaceuticals Inc.. The Redmile Group LLC’s holdings currently number 2,432,408 shares at $118482593.68. According to the firm’s last 13F report, Citadel Advisors LLC shares in the company at filing stood at 1,689,634 shares, roughly $86,103,749.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

What are analyst thoughts on Zentalis Pharmaceuticals Inc.?

Looking forward to the Zentalis Pharmaceuticals Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for Zentalis Pharmaceuticals Inc. stock at $60.00 within the next 12 months, which represents almost 18.82 per cent growth from its previous closing price of $48.71. The highest analysts’ target for Zentalis Pharmaceuticals Inc. stock projections is $75.00 and the lowest one is $43.00. Still, 5 analysts sharing their consensus rating for ZNTL stock in 2021 agree that it is a Buy.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Invitae Corporation Inc. (NVTA) stock surge during current market. Here’s the update:

Invitae Corporation Inc. (NASDAQ: NVTA) stock gains by 12.35% in the current market trading session. Invitae Corporation is a prominent medical genetics business whose...

Related News

The Aqua Metals (AQMS) Stock Is An Pre-Market Upsurge of 13% For What Reason?

The metal recycling firm Aqua Metals, Inc. (NASDAQ: AQMS) is on an uptick today in premarket session. As of 09:08 a.m. EST, the stock...

Insider Selling Report: Nu Skin Enterprises Inc. [NUS]’s Pres, Napierski Ryan S, Sells 4,844 Shares

On Jan. 07, Napierski Ryan S divested U.S. $286,038 in shares of Nu Skin Enterprises Inc.. The Pres sold 4,844 shares at a price...

Insider Alert: Harmonic Inc. [HLIT]’s SVP, Video R, D, Haltmayer Neven, Makes A $117,240 Sell

On Jan. 06, Haltmayer Neven divested U.S. $117,240 in shares of Harmonic Inc.. The SVP, Video R, D sold 15,632 shares at a price...

ACM Research Inc. [ACMR] Sees 2,000 Share Insider Sell From Dir Liu Tracy

On Jan. 06, Liu Tracy divested U.S. $200,000 in shares of ACM Research Inc.. The Dir sold 2,000 shares at a price per share...

Insider Selling: MasTec Inc. [MTZ] CFO Sells 30,027 Shares Worth $2,404,436

On Jan. 07, Pita George divested U.S. $2,404,436 in shares of MasTec Inc.. The CFO sold 30,027 shares at a price per share of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam